302 related articles for article (PubMed ID: 16919912)
41. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS
J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230
[TBL] [Abstract][Full Text] [Related]
42. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P
Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
[TBL] [Abstract][Full Text] [Related]
43. Soluble adhesion molecules in pediatric rheumatic diseases.
Bloom BJ; Miller LC; Blier PR
J Rheumatol; 2002 Apr; 29(4):832-6. PubMed ID: 11950029
[TBL] [Abstract][Full Text] [Related]
44. Antinucleosome antibody is a major autoantibody in localized scleroderma.
Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K
Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H
J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
[TBL] [Abstract][Full Text] [Related]
46. Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus.
Campos LM; Kiss MH; Scheinberg MA; Mangueira CL; Silva CA
Lupus; 2006; 15(8):496-500. PubMed ID: 16942001
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
48. Reactivities to the Sm autoantigenic complex and the synthetic SmD1-aa83-119 peptide in systemic lupus erythematosus and other autoimmune diseases.
Jaekel HP; Klopsch T; Benkenstein B; Grobe N; Baldauf A; Schoessler W; Werle E
J Autoimmun; 2001 Dec; 17(4):347-54. PubMed ID: 11771960
[TBL] [Abstract][Full Text] [Related]
49. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
Saisoong S; Eiam-Ong S; Hanvivatvong O
Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
[TBL] [Abstract][Full Text] [Related]
50. [Autoantibodies in systemic lupus erythematosus: spectrum and clinical associations].
Haddouk S; Ben Ayed M; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Pathol Biol (Paris); 2005 Jul; 53(6):311-7. PubMed ID: 16004941
[TBL] [Abstract][Full Text] [Related]
51. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.
Amital H; Heilweil-Harel M; Ulmansky R; Harlev M; Toubi E; Hershko A; Naparstek Y
Rheumatology (Oxford); 2007 Sep; 46(9):1433-7. PubMed ID: 17686790
[TBL] [Abstract][Full Text] [Related]
52. Correlation of serum measures of nitric oxide production with lupus disease activity.
Gilkeson G; Cannon C; Oates J; Reilly C; Goldman D; Petri M
J Rheumatol; 1999 Feb; 26(2):318-24. PubMed ID: 9972965
[TBL] [Abstract][Full Text] [Related]
53. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
54. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
55. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus.
Shergy WJ; Kredich DW; Pisetsky DS
J Rheumatol; 1988 Sep; 15(9):1389-94. PubMed ID: 3264338
[TBL] [Abstract][Full Text] [Related]
56. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
[TBL] [Abstract][Full Text] [Related]
57. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
Agmon-Levin N; Gilburd B; Kivity S; Katz BS; Flitman-Katzevman I; Shoenfeld N; Paran D; Langevitz P; Shoenfeld Y
Isr Med Assoc J; 2009 Jul; 11(7):403-6. PubMed ID: 19911490
[TBL] [Abstract][Full Text] [Related]
58. Patterns of autoantibody expression in pediatric and adult systemic lupus erythematosus.
Shergy WJ; Kredich DW; Pisetsky DS
J Rheumatol; 1989 Oct; 16(10):1329-34. PubMed ID: 2810258
[TBL] [Abstract][Full Text] [Related]
59. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy.
Abdel Gawad ER; Mansour AI; Abdel Aziz YA; Soliman AF; Fawzy RM
Egypt J Immunol; 2014; 21(1):57-65. PubMed ID: 25204045
[TBL] [Abstract][Full Text] [Related]
60. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
